GlassScriptPhysician profile
Mary A Fuchs
NPI 1790785301
$16,363.44
in general payments reported to CMS, 2019-2025
7 companies · $3,047 in 2025
The $3,047 reported for 2025 was more than what 97% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $365 · 2021: $552 · 2022: $775 · 2023: $6,481 · 2024: $4,948 · 2025: $3,047.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,142 · Food and Beverage: $4,206 · Travel and Lodging: $1,128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,141.75 |
| Food and Beverage | $4,206.35 |
| Travel and Lodging | $1,127.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14,113.66 | 2023-2025 | |
| Allergan, INC. | $1,360.29 | 2019-2022 | |
| Merz North America, INC. | $605.33 | 2020-2025 | |
| Galderma Laboratories, L.P. | $119.44 | 2019-2025 | Dysport |
| Janssen Pharmaceuticals, INC | $118.48 | 2019-2022 | |
| Novo Nordisk INC | $23.38 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $22.86 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Fuchs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.